BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9466490)

  • 1. Phosphatases and tumorigenesis.
    Parsons R
    Curr Opin Oncol; 1998 Jan; 10(1):88-91. PubMed ID: 9466490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer predisposition: where's the phosphate?
    Smith A; Ashworth A
    Curr Biol; 1998 Mar; 8(7):R241-3. PubMed ID: 9545192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
    Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
    Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
    [No Abstract]   [Full Text] [Related]  

  • 4. Cdc25 protein phosphatases in cell proliferation.
    Draetta G; Eckstein J
    Biochim Biophys Acta; 1997 Apr; 1332(2):M53-63. PubMed ID: 9141461
    [No Abstract]   [Full Text] [Related]  

  • 5. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
    Li DM; Sun H
    Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
    Chen J; Lindblom P; Lindblom A
    Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
    Unoki M; Nakamura Y
    Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement of protein tyrosine phosphatases in cancer development].
    Hinoda Y; Idogawa M; Imai K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1186-92. PubMed ID: 9655978
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CDC25A and CDC25B in head and neck cancers.
    Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
    Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
    Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
    Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
    Wishart MJ; Dixon JE
    Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mammalian expression system for rapid production and purification of active MAP kinase phosphatases.
    Chen P; Hutter D; Liu P; Liu Y
    Protein Expr Purif; 2002 Apr; 24(3):481-8. PubMed ID: 11922765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast.
    Li L; Ernsting BR; Wishart MJ; Lohse DL; Dixon JE
    J Biol Chem; 1997 Nov; 272(47):29403-6. PubMed ID: 9367992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.